0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Whole Genome and Exome Sequencing Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-9Z8229
Home | Market Reports | Science| Biological Sciences
Global and China Whole Genome and Exome Sequencing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Whole Genome and Exome Sequencing Market Research Report 2025

Code: QYRE-Auto-9Z8229
Report
June 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Whole Genome and Exome Sequencing Market Size

The global market for Whole Genome and Exome Sequencing was valued at US$ 360 million in the year 2024 and is projected to reach a revised size of US$ 758 million by 2031, growing at a CAGR of 11.4% during the forecast period.

Whole Genome and Exome Sequencing Market

Whole Genome and Exome Sequencing Market

Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
North American market for Whole Genome and Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Whole Genome and Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Whole Genome and Exome Sequencing in Hospitals and Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Whole Genome and Exome Sequencing include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings, Novogene Corporation, Oxford Nanopore Technologies, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Whole Genome and Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Genome and Exome Sequencing.
The Whole Genome and Exome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Whole Genome and Exome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whole Genome and Exome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Whole Genome and Exome Sequencing Market Report

Report Metric Details
Report Name Whole Genome and Exome Sequencing Market
Accounted market size in year US$ 360 million
Forecasted market size in 2031 US$ 758 million
CAGR 11.4%
Base Year year
Forecasted years 2025 - 2031
By Product
  • By Workflow
Segment by Application
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Labs
  • Research Centres, Academia and Government Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings, Novogene Corporation, Oxford Nanopore Technologies, Inc, Pacific Biosciences of California, Inc, QIAGEN N.V, Thermo Fisher Scientific Inc, Cytiva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Whole Genome and Exome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Whole Genome and Exome Sequencing Market growing?

Ans: The Whole Genome and Exome Sequencing Market witnessing a CAGR of 11.4% during the forecast period 2025-2031.

What is the Whole Genome and Exome Sequencing Market size in 2031?

Ans: The Whole Genome and Exome Sequencing Market size in 2031 will be US$ 758 million.

Who are the main players in the Whole Genome and Exome Sequencing Market report?

Ans: The main players in the Whole Genome and Exome Sequencing Market are Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings, Novogene Corporation, Oxford Nanopore Technologies, Inc, Pacific Biosciences of California, Inc, QIAGEN N.V, Thermo Fisher Scientific Inc, Cytiva

What are the Application segmentation covered in the Whole Genome and Exome Sequencing Market report?

Ans: The Applications covered in the Whole Genome and Exome Sequencing Market report are Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Diagnostic Labs, Research Centres, Academia and Government Institutes, Others

Recommended Reports

Sequencing Technologies

Genomic Services

Genomics Applications

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Product
1.2.3 By Workflow
1.3 Market by Application
1.3.1 Global Whole Genome and Exome Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Labs
1.3.5 Research Centres, Academia and Government Institutes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Genome and Exome Sequencing Market Perspective (2020-2031)
2.2 Global Whole Genome and Exome Sequencing Growth Trends by Region
2.2.1 Global Whole Genome and Exome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Whole Genome and Exome Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Whole Genome and Exome Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Whole Genome and Exome Sequencing Market Dynamics
2.3.1 Whole Genome and Exome Sequencing Industry Trends
2.3.2 Whole Genome and Exome Sequencing Market Drivers
2.3.3 Whole Genome and Exome Sequencing Market Challenges
2.3.4 Whole Genome and Exome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Genome and Exome Sequencing Players by Revenue
3.1.1 Global Top Whole Genome and Exome Sequencing Players by Revenue (2020-2025)
3.1.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Whole Genome and Exome Sequencing Revenue
3.4 Global Whole Genome and Exome Sequencing Market Concentration Ratio
3.4.1 Global Whole Genome and Exome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Genome and Exome Sequencing Revenue in 2024
3.5 Global Key Players of Whole Genome and Exome Sequencing Head office and Area Served
3.6 Global Key Players of Whole Genome and Exome Sequencing, Product and Application
3.7 Global Key Players of Whole Genome and Exome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Genome and Exome Sequencing Breakdown Data by Type
4.1 Global Whole Genome and Exome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2026-2031)
5 Whole Genome and Exome Sequencing Breakdown Data by Application
5.1 Global Whole Genome and Exome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Whole Genome and Exome Sequencing Market Size (2020-2031)
6.2 North America Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
6.4 North America Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Genome and Exome Sequencing Market Size (2020-2031)
7.2 Europe Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
7.4 Europe Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Whole Genome and Exome Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Genome and Exome Sequencing Market Size (2020-2031)
9.2 Latin America Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
9.4 Latin America Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Whole Genome and Exome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific SE
11.1.1 Eurofins Scientific SE Company Details
11.1.2 Eurofins Scientific SE Business Overview
11.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Introduction
11.1.4 Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.1.5 Eurofins Scientific SE Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Details
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.2.4 Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Beijing Genomics Institute (BGI)
11.3.1 Beijing Genomics Institute (BGI) Company Details
11.3.2 Beijing Genomics Institute (BGI) Business Overview
11.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Introduction
11.3.4 Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.3.5 Beijing Genomics Institute (BGI) Recent Development
11.4 Hoffmann-La Roche Ltd
11.4.1 Hoffmann-La Roche Ltd Company Details
11.4.2 Hoffmann-La Roche Ltd Business Overview
11.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Introduction
11.4.4 Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.4.5 Hoffmann-La Roche Ltd Recent Development
11.5 Bio-Rad Laboratories, Inc
11.5.1 Bio-Rad Laboratories, Inc Company Details
11.5.2 Bio-Rad Laboratories, Inc Business Overview
11.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Introduction
11.5.4 Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.5.5 Bio-Rad Laboratories, Inc Recent Development
11.6 GENEWIZ, Inc
11.6.1 GENEWIZ, Inc Company Details
11.6.2 GENEWIZ, Inc Business Overview
11.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Introduction
11.6.4 GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.6.5 GENEWIZ, Inc Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Details
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Whole Genome and Exome Sequencing Introduction
11.7.4 Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.7.5 Illumina, Inc Recent Development
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Details
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Introduction
11.8.4 Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.8.5 Laboratory Corporation of America Holdings Recent Development
11.9 Novogene Corporation
11.9.1 Novogene Corporation Company Details
11.9.2 Novogene Corporation Business Overview
11.9.3 Novogene Corporation Whole Genome and Exome Sequencing Introduction
11.9.4 Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.9.5 Novogene Corporation Recent Development
11.10 Oxford Nanopore Technologies, Inc
11.10.1 Oxford Nanopore Technologies, Inc Company Details
11.10.2 Oxford Nanopore Technologies, Inc Business Overview
11.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.10.4 Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.10.5 Oxford Nanopore Technologies, Inc Recent Development
11.11 Pacific Biosciences of California, Inc
11.11.1 Pacific Biosciences of California, Inc Company Details
11.11.2 Pacific Biosciences of California, Inc Business Overview
11.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.11.5 Pacific Biosciences of California, Inc Recent Development
11.12 QIAGEN N.V
11.12.1 QIAGEN N.V Company Details
11.12.2 QIAGEN N.V Business Overview
11.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Introduction
11.12.4 QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.12.5 QIAGEN N.V Recent Development
11.13 Thermo Fisher Scientific Inc
11.13.1 Thermo Fisher Scientific Inc Company Details
11.13.2 Thermo Fisher Scientific Inc Business Overview
11.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Introduction
11.13.4 Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.13.5 Thermo Fisher Scientific Inc Recent Development
11.14 Cytiva
11.14.1 Cytiva Company Details
11.14.2 Cytiva Business Overview
11.14.3 Cytiva Whole Genome and Exome Sequencing Introduction
11.14.4 Cytiva Revenue in Whole Genome and Exome Sequencing Business (2020-2025)
11.14.5 Cytiva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of By Product
 Table 3. Key Players of By Workflow
 Table 4. Global Whole Genome and Exome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Whole Genome and Exome Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Whole Genome and Exome Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Whole Genome and Exome Sequencing Market Share by Region (2020-2025)
 Table 8. Global Whole Genome and Exome Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Whole Genome and Exome Sequencing Market Share by Region (2026-2031)
 Table 10. Whole Genome and Exome Sequencing Market Trends
 Table 11. Whole Genome and Exome Sequencing Market Drivers
 Table 12. Whole Genome and Exome Sequencing Market Challenges
 Table 13. Whole Genome and Exome Sequencing Market Restraints
 Table 14. Global Whole Genome and Exome Sequencing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Whole Genome and Exome Sequencing Market Share by Players (2020-2025)
 Table 16. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome and Exome Sequencing as of 2024)
 Table 17. Ranking of Global Top Whole Genome and Exome Sequencing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Whole Genome and Exome Sequencing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Whole Genome and Exome Sequencing, Headquarters and Area Served
 Table 20. Global Key Players of Whole Genome and Exome Sequencing, Product and Application
 Table 21. Global Key Players of Whole Genome and Exome Sequencing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Whole Genome and Exome Sequencing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2020-2025)
 Table 25. Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2026-2031)
 Table 27. Global Whole Genome and Exome Sequencing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2020-2025)
 Table 29. Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2026-2031)
 Table 31. North America Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Whole Genome and Exome Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Eurofins Scientific SE Company Details
 Table 47. Eurofins Scientific SE Business Overview
 Table 48. Eurofins Scientific SE Whole Genome and Exome Sequencing Product
 Table 49. Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 50. Eurofins Scientific SE Recent Development
 Table 51. Agilent Technologies, Inc Company Details
 Table 52. Agilent Technologies, Inc Business Overview
 Table 53. Agilent Technologies, Inc Whole Genome and Exome Sequencing Product
 Table 54. Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 55. Agilent Technologies, Inc Recent Development
 Table 56. Beijing Genomics Institute (BGI) Company Details
 Table 57. Beijing Genomics Institute (BGI) Business Overview
 Table 58. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product
 Table 59. Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 60. Beijing Genomics Institute (BGI) Recent Development
 Table 61. Hoffmann-La Roche Ltd Company Details
 Table 62. Hoffmann-La Roche Ltd Business Overview
 Table 63. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product
 Table 64. Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 65. Hoffmann-La Roche Ltd Recent Development
 Table 66. Bio-Rad Laboratories, Inc Company Details
 Table 67. Bio-Rad Laboratories, Inc Business Overview
 Table 68. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product
 Table 69. Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 70. Bio-Rad Laboratories, Inc Recent Development
 Table 71. GENEWIZ, Inc Company Details
 Table 72. GENEWIZ, Inc Business Overview
 Table 73. GENEWIZ, Inc Whole Genome and Exome Sequencing Product
 Table 74. GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 75. GENEWIZ, Inc Recent Development
 Table 76. Illumina, Inc Company Details
 Table 77. Illumina, Inc Business Overview
 Table 78. Illumina, Inc Whole Genome and Exome Sequencing Product
 Table 79. Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 80. Illumina, Inc Recent Development
 Table 81. Laboratory Corporation of America Holdings Company Details
 Table 82. Laboratory Corporation of America Holdings Business Overview
 Table 83. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product
 Table 84. Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 85. Laboratory Corporation of America Holdings Recent Development
 Table 86. Novogene Corporation Company Details
 Table 87. Novogene Corporation Business Overview
 Table 88. Novogene Corporation Whole Genome and Exome Sequencing Product
 Table 89. Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 90. Novogene Corporation Recent Development
 Table 91. Oxford Nanopore Technologies, Inc Company Details
 Table 92. Oxford Nanopore Technologies, Inc Business Overview
 Table 93. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product
 Table 94. Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 95. Oxford Nanopore Technologies, Inc Recent Development
 Table 96. Pacific Biosciences of California, Inc Company Details
 Table 97. Pacific Biosciences of California, Inc Business Overview
 Table 98. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product
 Table 99. Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 100. Pacific Biosciences of California, Inc Recent Development
 Table 101. QIAGEN N.V Company Details
 Table 102. QIAGEN N.V Business Overview
 Table 103. QIAGEN N.V Whole Genome and Exome Sequencing Product
 Table 104. QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 105. QIAGEN N.V Recent Development
 Table 106. Thermo Fisher Scientific Inc Company Details
 Table 107. Thermo Fisher Scientific Inc Business Overview
 Table 108. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product
 Table 109. Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 110. Thermo Fisher Scientific Inc Recent Development
 Table 111. Cytiva Company Details
 Table 112. Cytiva Business Overview
 Table 113. Cytiva Whole Genome and Exome Sequencing Product
 Table 114. Cytiva Revenue in Whole Genome and Exome Sequencing Business (2020-2025) & (US$ Million)
 Table 115. Cytiva Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Whole Genome and Exome Sequencing Picture
 Figure 2. Global Whole Genome and Exome Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Whole Genome and Exome Sequencing Market Share by Type: 2024 VS 2031
 Figure 4. By Product Features
 Figure 5. By Workflow Features
 Figure 6. Global Whole Genome and Exome Sequencing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Whole Genome and Exome Sequencing Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals and Clinics Case Studies
 Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 10. Diagnostic Labs Case Studies
 Figure 11. Research Centres, Academia and Government Institutes Case Studies
 Figure 12. Others Case Studies
 Figure 13. Whole Genome and Exome Sequencing Report Years Considered
 Figure 14. Global Whole Genome and Exome Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Whole Genome and Exome Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Whole Genome and Exome Sequencing Market Share by Region: 2024 VS 2031
 Figure 17. Global Whole Genome and Exome Sequencing Market Share by Players in 2024
 Figure 18. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome and Exome Sequencing as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Whole Genome and Exome Sequencing Revenue in 2024
 Figure 20. North America Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
 Figure 22. United States Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
 Figure 26. Germany Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Whole Genome and Exome Sequencing Market Share by Region (2020-2031)
 Figure 34. China Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
 Figure 42. Mexico Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Whole Genome and Exome Sequencing Market Share by Country (2020-2031)
 Figure 46. Turkey Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Whole Genome and Exome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Eurofins Scientific SE Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 50. Agilent Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 51. Beijing Genomics Institute (BGI) Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 52. Hoffmann-La Roche Ltd Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 53. Bio-Rad Laboratories, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 54. GENEWIZ, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 55. Illumina, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 56. Laboratory Corporation of America Holdings Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 57. Novogene Corporation Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 58. Oxford Nanopore Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 59. Pacific Biosciences of California, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 60. QIAGEN N.V Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 61. Thermo Fisher Scientific Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 62. Cytiva Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart